The evidence that a vast majority of melanoma CTCs express “stem cell” markers such as ABCB5, shown by flow cytometry and PAX3, by gene expression, argues for inclusion of such markers to increase the CTC detection rate by immunocytochemistry. The gene discussed is PAX3; the disease is melanoma.